Published in J Neuroimmune Pharmacol on October 10, 2013
Cognitive impairment in patients with AIDS - prevalence and severity. HIV AIDS (Auckl) (2015) 0.96
HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int (2015) 0.89
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium. J Neuroimmune Pharmacol (2015) 0.83
Factors related to HIV-associated neurocognitive impairment differ with age. J Neurovirol (2014) 0.78
Biomarkers for NeuroAIDS: recent progress in the field. J Neuroimmune Pharmacol (2013) 0.78
Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment. J Neuroimmune Pharmacol (2017) 0.75
Depression and diagnosis of neurocognitive impairment in HIV-positive patients. Braz J Med Biol Res (2016) 0.75
More than two HANDs to tango. J Neuroimmune Pharmacol (2013) 0.75
Cognitive Impairment among Persons of Rural Background Living with Human Immunodeficiency Virus Infection on Antiretroviral Therapy: A Study from a Tertiary Care Centre of North India. J Neurosci Rural Pract (2016) 0.75
Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen. AIDS (2017) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
A comparison of goodness-of-fit tests for the logistic regression model. Stat Med (1997) 8.51
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56
The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67
The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology (2009) 4.07
Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology (2004) 3.44
The incidence of dementia: a meta-analysis. Neurology (1998) 3.06
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45
Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med (1994) 2.39
CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS (2011) 2.31
Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol (2007) 2.27
Cognitive impairment and medication adherence in outpatients with heart failure. Heart Lung (2012) 2.18
Neurologic complications of HIV disease and their treatment. Top HIV Med (2010) 2.14
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02
Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol (2001) 1.91
Trends in predicted 10-year risk of coronary heart disease and cardiovascular disease among U.S. adults from 1999 to 2010. J Am Coll Cardiol (2013) 1.81
Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc (2007) 1.54
Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology (2011) 1.49
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder. Neurology (2012) 1.48
Incidence and impact on mortality of severe neurocognitive disorders in persons with and without HIV infection: a Danish nationwide cohort study. Clin Infect Dis (2011) 1.37
Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol (1996) 1.33
Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months. J Clin Exp Neuropsychol (2000) 1.32
The effect of education and occupational complexity on rate of cognitive decline in Alzheimer's patients. J Int Neuropsychol Soc (2006) 1.31
Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis (2012) 1.31
Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses (2003) 1.29
The Effects of Age and HIV on Neuropsychological Performance. J Int Neuropsychol Soc (2010) 1.25
Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr (2013) 1.21
Lower cognitive reserve among individuals with syndromic HIV-associated neurocognitive disorders (HAND). AIDS Behav (2012) 1.19
The utility of a rapid screening tool for depression and HIV dementia amongst patients with low CD4 counts- a preliminary report. Afr J Psychiatry (Johannesbg) (2008) 1.17
The relationship between employment and neuropsychological impairment in HIV infection. J Int Neuropsychol Soc (1999) 1.15
Validity of the International HIV Dementia Scale in South Africa. AIDS Patient Care STDS (2011) 1.11
Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS (2013) 1.10
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci (2009) 1.07
The relationship between age and cognitive function in HIV-infected men. J Neuropsychiatry Clin Neurosci (2005) 1.02
Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools. Top Antivir Med (2011) 1.02
Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample. AIDS Care (2005) 0.97
A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale. PLoS One (2013) 0.97
Performances on the CogState and standard neuropsychological batteries among HIV patients without dementia. AIDS Behav (2011) 0.96
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol (2013) 0.96
Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000-2009. Am J Prev Med (2012) 0.95
Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease. AIDS Patient Care STDS (2011) 0.94
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients. HIV Med (2012) 0.93
HIV-related neurocognitive impairment in the HAART era. Curr HIV/AIDS Rep (2009) 0.93
Neurocognitive functioning is associated with employment status: a quantitative review. J Clin Exp Neuropsychol (2003) 0.89
Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS. Indian J Psychiatry (2012) 0.82
Resting state functional connectivity of the striatum in Parkinson's disease. Brain (2012) 2.53
Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis (2007) 2.34
Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J Neurosci (2012) 2.26
Neurologic complications of HIV disease and their treatment. Top HIV Med (2010) 2.14
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med (2015) 1.94
Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology (2013) 1.82
Temporal dynamics of brain tissue nitric oxide during functional forepaw stimulation in rats. Neuroimage (2003) 1.67
Cerebrospinal fluid Aβ42, phosphorylated Tau181, and resting-state functional connectivity. JAMA Neurol (2013) 1.60
HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Technology insight: can neuroimaging provide insights into the role of ischemia in Baló's concentric sclerosis? Nat Clin Pract Neurol (2007) 1.57
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses (2012) 1.35
The aging of the HIV epidemic. Curr HIV/AIDS Rep (2008) 1.27
Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology (2013) 1.16
Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke (2005) 1.14
Baló's concentric sclerosis presenting as a stroke-like syndrome. Nat Clin Pract Neurol (2007) 1.14
Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Med (2013) 1.10
Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects. J Infect Dis (2012) 1.06
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the United States. Sex Transm Dis (2012) 1.03
Impaired and facilitated functional networks in temporal lobe epilepsy. Neuroimage Clin (2013) 1.01
FLAIR vascular hyperintensity may predict stroke after TIA. Clin Neurol Neurosurg (2007) 0.99
Alzheimer disease family history impacts resting state functional connectivity. Ann Neurol (2012) 0.97
The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol (2013) 0.96
Role of magnetic resonance imaging, cerebrospinal fluid, and electroencephalogram in diagnosis of sporadic Creutzfeldt-Jakob disease. J Neurol (2012) 0.96
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Ann Intern Med (2015) 0.95
Neuroimaging markers of human immunodeficiency virus infection in South Africa. J Neurovirol (2012) 0.95
Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol (2007) 0.94
Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy. AIDS Res Hum Retroviruses (2011) 0.94
STD/HIV risk among adults in the primary care setting: are we adequately addressing our patients' needs? Sex Transm Dis (2011) 0.94
The effects of HIV and combination antiretroviral therapy on white matter integrity. AIDS (2012) 0.93
Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS (2011) 0.91
Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS (2012) 0.91
A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need? AIDS (2015) 0.90
Role of HIV in amyloid metabolism. J Neuroimmune Pharmacol (2014) 0.90
HIV clades B and C are associated with reduced brain volumetrics. J Neurovirol (2013) 0.88
Luminance contrast of a visual stimulus modulates the BOLD response more than the cerebral blood flow response in the human brain. Neuroimage (2012) 0.87
Network dysfunction in Alzheimer's disease: refining the disconnection hypothesis. Brain Connect (2014) 0.86
Cerebral white matter integrity during primary HIV infection. AIDS (2015) 0.85
Central nervous system complications of HIV infection. Top Antivir Med (2011) 0.84
Efavirenz outperforms boosted atazanavir among treatment-naive HIV-1-infected persons in routine clinical care. J Int Assoc Provid AIDS Care (2012) 0.83
Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity. AIDS (2015) 0.83
Impact of human immunodeficiency virus on neurocognition and risky behaviors in young adults. J Neurovirol (2014) 0.82
Comparison of regional cerebral blood flow responses to hypoglycemia using pulsed arterial spin labeling and positron emission tomography. PLoS One (2013) 0.81
Diagnosis and evaluation of a patient with rapidly progressive dementia. Mo Med (2013) 0.81
Coupling of cerebral blood flow and oxygen metabolism is conserved for chromatic and luminance stimuli in human visual cortex. Neuroimage (2012) 0.80
Perceptions of alcohol risk among individuals living with HIV. AIDS Care (2011) 0.79
Neurologic complications of HIV infection: highlights from the 2013 Conference on Retroviruses and Opportunistic Infections. Top Antivir Med (2013) 0.79
Neurologic complications of HIV infection. Top Antivir Med (2012) 0.79
The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals. J Neuroimmune Pharmacol (2015) 0.79
Advances in diagnostic testing for Alzheimer disease. Mo Med (2013) 0.78
Depression severity is associated with increased risk behaviors and decreased CD4 cell counts. AIDS Care (2014) 0.78
Sometimes, more is better. J Infect Dis (2012) 0.78
Screening anxiety in the HIV clinic. AIDS Behav (2012) 0.77
Reply to Ganesan et al. J Infect Dis (2011) 0.76
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76
The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Alzheimer Dis Assoc Disord (2014) 0.76
Tumefactive demyelination in a patient with human immunodeficiency virus. J Neurovirol (2013) 0.75
Susac syndrome in a patient with human immunodeficiency virus infection. J Neurovirol (2013) 0.75
Relationships among HIV infection, metabolic risk factors, and left ventricular structure and function. AIDS Res Hum Retroviruses (2013) 0.75
Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One (2016) 0.75
Putamen volume and its clinical and neurological correlates in primary HIV infection. AIDS (2016) 0.75
Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era. J Acquir Immune Defic Syndr (2017) 0.75
Diffusion Basis Spectral Imaging Detects Ongoing Brain Inflammation in Virologically Well Controlled HIV+ Patients. J Acquir Immune Defic Syndr (2017) 0.75
Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. Alzheimer Dis Assoc Disord (2017) 0.75
Preliminary outcomes of a pilot physical therapy program for HIV-infected patients with chronic pain. AIDS Care (2014) 0.75